TVGN
TVGN
NASDAQ · Biotechnology

Tevogen Bio Holdings Inc

$6.31
-0.27 (-4.10%)
As of Aug 18, 10:22 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +232.2% upside
Low Target $15.05
Average Target $20.96
High Target $24.54
Current Price $6.31
Current
$6.31
Target
$20.96
$15.05 $20.96 avg $24.54
Scenario Analysis
Bear Case
$15.05
138.5%
Low target
Base Case
$20.96
+232.2%
Avg target
Bull Case
$24.54
+288.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$55.00
-88.5% from high
52-Week Low
$3.64
+73.5% from low
Target vs 52W High
$20.96
-61.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -0.5%
AMGN
Amgen Inc
Hold 43 49% $190.87 -55.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +152.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -54.1%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -47.2%
BIIB
Biogen Inc
Buy 43 67% $91.45 -57.0%